Alerta Bibliográfica

1. SCHETT G, Saag KG, Bijlsma JW.
From bone biology to clinical outcome: state of the art and future perspectives.
Ann Rheum Dis. 2010;69:1415-9.
http://amedeo.com/p2.php?id=20650876&s=rhe&pm=352014ef2974a30
ABSTRACT available


2. HULTQVIST M, Nandakumar KS, Bjorklund U, Holmdahl R, et al.
Rabeximod reduces arthritis severity in mice by decreasing activation of
inflammatory cells.
Ann Rheum Dis. 2010;69:1527-32.
http://amedeo.com/p2.php?id=20542961&s=rhe&pm=352014ef2974a30
ABSTRACT available


3. VILCA I, Munitis PG, Pistorio A, Ravelli A, et al.
Predictors of poor response to methotrexate in polyarticular-course juvenile
idiopathic arthritis: analysis of the PRINTO methotrexate trial.
Ann Rheum Dis. 2010;69:1479-83.
http://amedeo.com/p2.php?id=20525842&s=rhe&pm=352014ef2974a30
ABSTRACT available


4. FREY O, Meisel J, Hutloff A, Bonhagen K, et al.
Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T
helper 1/T helper 17 cells and mitigates autoimmune arthritis.
Ann Rheum Dis. 2010;69:1495-501.
http://amedeo.com/p2.php?id=20498202&s=rhe&pm=352014ef2974a30
ABSTRACT available


5. VAN DER WOUDE D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, et al.
Epitope spreading of the anti-citrullinated protein antibody response occurs
before disease onset and is associated with the disease course of early
arthritis.
Ann Rheum Dis. 2010;69:1554-61.
http://amedeo.com/p2.php?id=20448290&s=rhe&pm=352014ef2974a30
ABSTRACT available


6. THURLINGS RM, Boumans M, Tekstra J, van Roon JA, et al.
The relationship between the type I interferon signature and the response to
rituximab in rheumatoid arthritis.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20722020&s=rhe&pm=352014ef2974a30
ABSTRACT available


7. BOERS M, Kostense PJ.
Non-overlapping ACR response rates: A better way to report response in rheumatoid
arthritis clinical trials.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20722016&s=rhe&pm=352014ef2974a30
ABSTRACT available


8. MIKULS TR, Sayles H, Yu F, Levan T, et al.
Associations of cigarette smoking with rheumatoid arthritis in African Americans.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20722010&s=rhe&pm=352014ef2974a30
ABSTRACT available


9. STRAND V, Khanna D.
The impact of rheumatoid arthritis and treatment on patients' lives.
Clin Exp Rheumatol. 2010;28.
http://amedeo.com/p2.php?id=20576223&s=rhe&pm=352014ef2974a30
ABSTRACT available


10. SMOLEN JS, Aletaha D.
The assessment of disease activity in rheumatoid arthritis.
Clin Exp Rheumatol. 2010;28.
http://amedeo.com/p2.php?id=20576221&s=rhe&pm=352014ef2974a30
ABSTRACT available


11. FURST DE.
Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis.
Clin Exp Rheumatol. 2010;28.
http://amedeo.com/p2.php?id=20576219&s=rhe&pm=352014ef2974a30
ABSTRACT available


12. FERRARI R, Russell AS.
Correlations between coping styles and symptom expectation for rheumatoid
arthritis.
Clin Rheumatol. 2010.
http://amedeo.com/p2.php?id=20714764&s=rhe&pm=352014ef2974a30
ABSTRACT available


13. KOLLY L, Busso N, Palmer G, Talabot-Ayer D, et al.
Expression and function of the NALP3 inflammasome in rheumatoid synovium.
Immunology. 2010;129:178-85.
http://amedeo.com/p2.php?id=19824913&s=rhe&pm=352014ef2974a30
ABSTRACT available


14. OSTILE IL, Johansson I, Aasland A, Flato B, et al.
Self-rated physical and psychosocial health in a cohort of young adults with
juvenile idiopathic arthritis.
Scand J Rheumatol. 2010;39:318-25.
http://amedeo.com/p2.php?id=20476866&s=rhe&pm=352014ef2974a30
ABSTRACT available


-- Desde Mi iPhone